pharmatechoutlook
knowledge

The Past Decade of Quality by Design: A Perspective Overview
Pharmatechoutlook >> cxoinsights

Brad Swarbrick, Owner, Quality by Design Consultancy

In 2011 when the US Food and Drug Administration (US-FDA) published their guidance document on Process Validation (PV), this represented the first real attempt by a regulatory authority to mandate the implementation of the Quality by Design...

The Past Decade of Quality by Design: A Perspective Overview
Pharmatechoutlook >> cxoinsights

Brad Swarbrick, Owner, Quality by Design Consultancy

In 2011 when the US Food and Drug Administration (US-FDA) published their guidance document on Process Validation (PV), this represented the first real attempt by a regulatory authority to mandate the implementation of the Quality by Design...

The Past Decade of Quality by Design: A Perspective Overview
Pharmatechoutlook >> cxoinsights

Brad Swarbrick, owner, Quality by Design Consultancy

Introduction In 2011 when the US Food and Drug Administration (US-FDA) published their guidance document on Process Validation (PV), this represented the first real attempt by a regulatory authority to mandate the implementation of the Quality...

The Past Decade of Quality by Design: A Perspective Overview
Pharmatechoutlook >> cxoinsights

Brad Swarbrick, owner, Quality by Design Consultancy

Introduction In 2011 when the US Food and Drug Administration (US-FDA) published their guidance document on Process Validation (PV), this represented the first real attempt by a regulatory authority to mandate the implementation of the Quality...

STEER Utilizes Six Sigma Framework and Process Analytics for Better Medicine Practices
Pharmatechoutlook >> news

FREMONT, CA: STEER, the producer of the material and technology platform, introduces its new technology and solutions -STEERLIFE which aims to redesign the global pharmaceutical industry by modifying the nature of medicine previously made and...

Health Information Made Easy to Make People Healthier
Pharmatechoutlook >> cioviewpoint

Gray Knowlton, CIO, Upsher-Smith Laboratories

Big Challenge in Technology Our industry is moving toward individualized, targeted solutions for improving a person’s health. Aligning incentives with outcome-driven care is difficult in our current environment. Research toward...

Covering All Aspects of Analytics
Pharmatechoutlook >> cxoinsights

Paul Kallukaran, Executive Director, Global Commercial Business Analytics

When Merck IT decided to focus on analytics, the intent was clear – empower the company to identify insights and make data-driven decisions that have the potential to solve important problems and drive shareholder value. While the goal may...

Covering All Aspects of Analytics
Pharmatechoutlook >> cxoinsights

Paul Kallukaran, Executive Director, Global Commercial Business Analytics

When Merck IT decided to focus on analytics, the intent was clear – empower the company to identify insights and make data-driven decisions that have the potential to solve important problems and drive shareholder value. While the goal may...

81qd: Analytics to Improve Patient Outcomes
Pharmatechoutlook >> vendor

Bob Gabruk, Managing Director

Customized, cost-effective health care data analytics solutions to maximize the commercial potential of biopharmaceutical products. An advanced health care data analytics company whose offerings are customized, high-value, brand-specific,...

Excelra: Intelligent Analytics for Effective Drug Discovery
Pharmatechoutlook >> vendor

Anandbir Singh Brar, CEO

Excelera provides intelligent data and analytics solutions to life sciences and pharma organizations globally
Top 10 Clinical Data Management Solution Providers 2017

Clinical Data Management Special